Tourmaline Bio Inc. (TRML)

AI Score

Unlock

16.01

1.49 (10.26%)

At close: Apr 17, 2025, 3:59 PM

16.00

-0.06%

After-hours: Apr 17, 2025, 07:16 PM EDT

Tourmaline Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	30.51M	35.01M	70.15M	98.29M	140.73M	67.08M	87.09M	24.22M	8.26M	18.47M	25.52M	22.79M	18.61M	27.31M	36.3M	9.89M	17.59M
Short-Term Investments	227.8M	246.92M	219.38M	194.77M	62.23M	79.94M	133.9M	141.59M	167.61M	175.4M	181.59M	202.74M	225.36M	227.42M	229.92M	130.21M	131.9M
Long-Term Investments	36.63M	32.47M	45.1M	57.24M	-62.16M	n/a	250K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	3.26M	1.89M	1.2M	1.43M	63.14M	13.51K	2.29M	111K	216K	278K	111K	111K	104K	104K	89K	1.3M	14K
Receivables	n/a	n/a	n/a	n/a	n/a	1.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	477K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	1.18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	10.54M	11.86M	8.59M	7.04M	5.92M	1.49M	n/a	913K	n/a	777K	889K	797K	640K	854K	634K	67K	459K
Total Current Assets	268.84M	293.79M	298.13M	300.1M	208.87M	151.05M	88.54M	168.86M	8.31M	197.96M	212.04M	228.42M	246.51M	258.23M	270.47M	141.51M	150.75M
Property-Plant & Equipment	267K	307K	355K	402K	447K	490.00	521K	3.64M	570K	8.31M	8.77M	8.72M	4.8M	2.99M	2.25M	2.08M	2.01M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	40.16M	34.66M	46.66M	59.07M	1.42M	14K	3.06M	3.75M	786K	8.58M	8.88M	8.83M	4.91M	3.1M	2.34M	3.39M	2.03M
Total Assets	309M	328.45M	344.79M	359.17M	210.29M	151.06M	91.61M	172.61M	9.1M	206.54M	220.92M	237.25M	251.42M	261.32M	272.81M	144.9M	152.78M
Account Payables	3.58M	2.05M	2.39M	1.94M	1.07M	136K	2.43M	3.38M	401K	2.13M	2.08M	3.48M	2.56M	1.18M	1.26M	769K	767K
Deferred Revenue	n/a	n/a	n/a	2.67M	3.71M	7.29M	3.32M	n/a	799.04K	n/a	n/a	-1	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	227K	n/a	224K	n/a	221K	n/a	n/a	751K	n/a	905K	835K	740K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	3.83M	2.79M	1.8M	1.84M	1.77M	5.84M	2.06M	2.84M	446K	2.73M	1.92M	1.91M	2.11M	1.59M	1.95M	2.1M	1.24M
Total Current Liabilities	8.91M	7.28M	6.36M	4.83M	5M	8.11M	6.02M	10.18M	1.36M	9.17M	7.33M	8.06M	7.99M	4.98M	4.66M	3.58M	3.4M
Long-Term Debt	17K	n/a	n/a	n/a	194K	n/a	n/a	307K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	23K	31K	39K	50K	-137K	82K	127.85M	-131K	27.13M	310K	413K	492K	626K	694K	800K	1.63M	1.37M
Total Long-Term Liabilities	40K	95K	148K	203K	251K	82K	128.12M	697K	27.47M	2.51M	2.84M	3.15M	626K	694K	800K	1.63M	1.37M
Total Liabilities	8.95M	7.38M	6.51M	5.03M	5.25M	8.19M	134.13M	10.88M	28.83M	11.68M	10.17M	11.22M	8.61M	5.68M	5.46M	5.21M	4.77M
Total Debt	244K	290K	333K	376K	415K	634K	489K	1.27M	504K	3.1M	3.27M	3.4M	n/a	n/a	n/a	n/a	n/a
Common Stock	3K	3K	3K	3K	2K	1.00	1K	4K	4K	4K	4K	4K	4K	4K	4K	1K	1K
Retained Earnings	-135.26M	-113.03M	-92.85M	-75.36M	-62.05M	-208.99M	-43.56M	-187.24M	-19.93M	-146.21M	-127.2M	-109.11M	-90.85M	-76.61M	-63.66M	-52.31M	-43.01M
Comprehensive Income	296K	821K	-452K	-253K	67K	-115K	899.2K	-299K	-721K	-1.22M	-1.14M	-926K	-78K	29K	34K	9K	-13K
Shareholders Equity	300.05M	321.07M	338.28M	354.14M	205.04M	142.87M	-42.53M	161.73M	-19.73M	194.87M	210.74M	226.03M	242.81M	255.65M	267.35M	139.69M	148M
Total Investments	264.43M	279.38M	264.49M	252.01K	62.23K	79.94M	134.15M	141.59M	167.61M	175.4M	181.59M	202.74M	225.36M	227.42M	229.92M	130.21M	131.9M